Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended Infant Post-exposure Prophylaxis for HIV Prevention (PEPI-Malawi)
NCT00115648Phase 3Completed
- Sponsor
- Johns Hopkins Bloomberg School of Public Health
- Start
- Apr 2004
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nevirapine, zidovudine in human immunodeficiency virus infection (HIV), sponsored by Johns Hopkins Bloomberg School of Public Health. Started Apr 2004; status: completed.
02
Drugs
nevirapinezidovudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00115648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00115648.